Uncovering the facts, Holding government accountable.
Published: September 4, 2019
FOIA to FDA Seeking Email Communications Between FDA Officials and Mar-a-Lago Trio
FOIA request to the U.S. Food & Drug Administration seeking email communications between FDA officials and the Mar-a-Lago Trio regarding the anti-depressant nasal spray Spravato (esketamine). HHS-FDA-19-1104
Select a tag below to see a full list of related documents